Notably, NNT-AS1 also showed a high expression level in drug-resistant NSCLC, which promoted the cisplatin resistance of cancer cells via the MAPK/Slug pathway [36]. The gene discussed is SNAI2; the disease is non-small cell lung carcinoma.